Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03190317 · ClinicalTrials.gov registry record
Health Information for Infected Veterans
A clinical trial of Human Immunodeficiency Virus, sponsored by VA Office of Research and Development.
- Active
- Registry status
- 123
- Enrollment target
- 8
- Study locations
NCT03190317: Active study of Human Immunodeficiency Virus, sponsored by VA Office of Research and Development.
NCT03190317 is a study of Human Immunodeficiency Virus that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 123 participants, below the 181-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (32% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03190317, a study of Human Immunodeficiency Virus, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- 123 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is a study of My HealtheVet (MHV) use by Veterans diagnosed with Human Immunodeficiency Virus (HIV) and VA providers/staff who care for them. The investigators hope to learn and understand how MHV can improve the self-management of chronic conditions like HIV. First, the investigators will review Veteran medical records to look at the relationship between use of MHV and whether it has a positive or negative impact on the Veteran's management of HIV. Next, the investigators will interview participants to find out how MHV for self-management is used by Veterans and to find out why Veterans and providers choose to use (or not use) specific MHV tools. Lastly, the investigators will use the information found from the first two steps and create an intervention that will encourage non-MHV users to use the MHV tools that can help achieve health-related goals. Once the intervention has been developed, Veterans and providers will participate in a "cognitive walkthrough" to help the researchers test the intervention to see if it is usable, possible, and acceptable.
Primary Outcome
Determine the relationship between MHV tools and quality of care and outcomes for Veterans who are HIV positive.
Conditions Studied
Interventions
- OTHER HIV-infected Veterans who use MHV
- OTHER HIV-infected Veterans who do not use MHV
- OTHER Providers and staff of HIV-infected veteran
Study Locations (8)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
- VA San Diego Healthcare System, San Diego, CA - San Diego
Florida
- Orlando VA Medical Center, Orlando, FL - Orlando
Indiana
- Richard L. Roudebush VA Medical Center, Indianapolis, IN - Indianapolis
Maryland
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore
Massachusetts
- VA Bedford HealthCare System, Bedford, MA - Bedford
Nevada
- VA Southern Nevada Healthcare System, North Las Vegas, NV - Las Vegas
New York
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2019-06-24 |
| Est. Completion | 2025-09-30 |
What the registry record for NCT03190317 still lists
NCT03190317 is an observational study that tracks outcomes without assigning an intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, below the 181-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (32% lower).
The record links to 1 condition, with Human Immunodeficiency Virus appearing as the primary indexed condition, and to 3 interventions - of which HIV-infected Veterans who use MHV is the first listed.
NCT03190317 lists 8 locations in 7 states (California, Florida, Indiana).
Frequently Asked Questions
What is clinical trial NCT03190317 about?
NCT03190317 is a clinical study titled "Health Information for Infected Veterans". This is a study of My HealtheVet (MHV) use by Veterans diagnosed with Human Immunodeficiency Virus (HIV) and VA providers/staff who care for them. The investigators hope to learn and understand how MHV can improve the self-management of chronic conditions like HIV. First, the investigators will revi...
What is the current status of trial NCT03190317?
This trial is currently active not recruiting. The enrollment target is 123 participants. The study started on 2019-06-24. Estimated completion is 2025-09-30.
What conditions does trial NCT03190317 study?
This clinical trial studies the following conditions: Human Immunodeficiency Virus.
What interventions are being tested in trial NCT03190317?
The interventions under investigation include: HIV-infected Veterans who use MHV (OTHER), HIV-infected Veterans who do not use MHV (OTHER), Providers and staff of HIV-infected veteran (OTHER).
Who is sponsoring clinical trial NCT03190317?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03190317 being conducted?
This trial has 8 study locations across California, Florida, Indiana, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Immunodeficiency Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03190317's enrollment target sits among peer trials
123 15th of 39 higher than 25 of 39 other Human Immunodeficiency Virus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Human Immunodeficiency Virus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
Baricitinib for Reduction of HIV - CNS
RECRUITING · Phase 2
-
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
RECRUITING · Phase 2
-
Harm Reduction in HIV Primary Care for PLWH Who Use Drugs
RECRUITING
-
Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors
RECRUITING
-
V+PSF-M for Tobacco Cessation in HIV Care in India
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI